title: Bevacizumab-induced nasal septum perforation.
authors.forename: Marwan G
authors.initials: MG
authors.lastname: Fakih
authors.forename: Jeffrey C
authors.initials: JC
authors.lastname: Lombardo
mesh_terms: D000911:Antibodies, Monoclonal / Q000009:adverse effects*; D061067:Antibodies, Monoclonal, Humanized; D000970:Antineoplastic Agents / Q000009:adverse effects*; D000068258:Bevacizumab; D006801:Humans; D008297:Male; D008875:Middle Aged; D009300:Nasal Septum; D009668:Nose Diseases / Q000139:chemically induced*
chemical_list: D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D000970:Antineoplastic Agents; D000068258:Bevacizumab